A Comparison of Manual and Automatic Methods for Calculating Cumulative Dose-Volume Histogram Parameters in Cervical Cancer Radiotherapy

Background: The cumulative dose-volume histogram (DVH) parameters for organs at risk (OAR) and the target volume, obtained from external beam radiotherapy (EBRT) and brachytherapy (BT), are commonly calculated manually in clinical practice. Objectives: This study aims at comparing the manual and automatic methods for calculating cumulative DVH parameters of OAR and the target volume in patients with cervical cancer. Methods: The cumulative DVH of EBRT and BT methods for target volume and OAR, including rectum, bladder, and sigmoid was calculated manually, using the EQD2 (equivalent dose in 2 Gy fractions) formula. In the automatic method, dosimetric data were collected as DICOM files and entered into SagiPlan® BT software. Using the BED/EQD2 summation feature, the BT and EBRT plans were summed, and the cumulative DVH parameters were extracted. The results were compared with the manual method. Results: In 32 cervical cancer samples, dosimetric comparisons showed significant differences between manual (EQD2) and automatic (SagiPlan®) calculations for rectum (mean dose 69.15 vs. 71.92 Gy, P < 0.01), bladder (mean dose 81.87 vs. 84.47 Gy, P < 0.01), and sigmoid (mean dose 69.84 vs.73.15 Gy, P < 0.01). However, the cumulative dose to the target tissue was similar between the two methods (mean dose 86.9 vs. 86.91, P = 0.21). Automatic calculations indicated higher doses of the OARs, suggesting potential underestimation by manual methods. Conclusions: In clinical practice, when designing BT planning for cervical cancer, it is recommended to input the patient’s EBRT design data into the planning software to determine the cumulative dose received by the target and OARs.

Authors

Institutions

Publication Details

Journal
International Journal of Cancer Management
Published
2024-12-06
DOI
https://doi.org/10.5812/ijcm-156839
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Comparison of Manual and Automatic Methods for Calculating Cumulative Dose-Volume Histogram Parameters in Cervical Cancer Radiotherapy

Farid Farajollahi, Zahra Siavashpour, Samira Azghandi, Mohammad Houshyari et al.
International Journal of Cancer Management
Endometrial and Cervical Cancer Treatments
article

A Comparison of Manual and Automatic Methods for Calculating Cumulative Dose-Volume Histogram Parameters in Cervical Cancer Radiotherapy

Farid Farajollahi, Zahra Siavashpour, Samira Azghandi, Mohammad Houshyari, Seyed Mahmoud Reza Aghamiri
article en

Abstract

Background: The cumulative dose-volume histogram (DVH) parameters for organs at risk (OAR) and the target volume, obtained from external beam radiotherapy (EBRT) and brachytherapy (BT), are commonly calculated manually in clinical practice. Objectives: This study aims at comparing the manual and automatic methods for calculating cumulative DVH parameters of OAR and the target volume in patients with cervical cancer. Methods: The cumulative DVH of EBRT and BT methods for target volume and OAR, including rectum, bladder, and sigmoid was calculated manually, using the EQD2 (equivalent dose in 2 Gy fractions) formula. In the automatic method, dosimetric data were collected as DICOM files and entered into SagiPlan® BT software. Using the BED/EQD2 summation feature, the BT and EBRT plans were summed, and the cumulative DVH parameters were extracted. The results were compared with the manual method. Results: In 32 cervical cancer samples, dosimetric comparisons showed significant differences between manual (EQD2) and automatic (SagiPlan®) calculations for rectum (mean dose 69.15 vs. 71.92 Gy, P < 0.01), bladder (mean dose 81.87 vs. 84.47 Gy, P < 0.01), and sigmoid (mean dose 69.84 vs.73.15 Gy, P < 0.01). However, the cumulative dose to the target tissue was similar between the two methods (mean dose 86.9 vs. 86.91, P = 0.21). Automatic calculations indicated higher doses of the OARs, suggesting potential underestimation by manual methods. Conclusions: In clinical practice, when designing BT planning for cervical cancer, it is recommended to input the patient’s EBRT design data into the planning software to determine the cumulative dose received by the target and OARs.

International Journal of Cancer ManagementVol. 17(1)
Shahid Beheshti University (IR), Shahid Beheshti University of Medical Sciences (IR)
Good health and well-being
Openalex Percentile: Top 65%
Endometrial and Cervical Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.